白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2010年
5期
290-292
,共3页
杨雷%龚玉萍%杨曦%周睿卿%郑波慧%邢宏运%何光翠
楊雷%龔玉萍%楊晞%週睿卿%鄭波慧%邢宏運%何光翠
양뢰%공옥평%양희%주예경%정파혜%형굉운%하광취
淋巴瘤%病理学,临床%肿瘤分期%肿瘤,各部位
淋巴瘤%病理學,臨床%腫瘤分期%腫瘤,各部位
림파류%병이학,림상%종류분기%종류,각부위
Lymphoma%Pathology,clinic%Neoplasms staging%Neoplasms by site
目的 分析恶性淋巴瘤患者住院的临床特点.方法 从该院病案数据库提取2005年1月至2009年12月住院恶性淋巴瘤患者的资料,剔除未能明确病理分型及重复入院的病例,从年龄、性别、病理类型、肿瘤起病部位及分期等方面进行分析、总结.结果 住院的恶性淋巴瘤患者1126例,男女比例为1.94:1.霍奇金淋巴瘤(HL)患者年龄集中在20～40岁,以混合细胞型(64.16%)、结节硬化型(29.48%)为主.非霍奇金淋巴瘤(NHL)患者年龄以50～70岁为多,发病率位于前10位的为弥漫大B细胞淋巴瘤(53.31%)、结外NK/T细胞淋巴瘤(7.35%)、套细胞淋巴瘤(6.40%)、B细胞慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(4.30%)、间变性大细胞淋巴瘤(4.09%)、前T细胞淋巴母细胞白血病/淋巴瘤(3.88%)、外周T细胞淋巴瘤(非特指)(3.46%)、血管免疫母细胞型淋巴瘤(3.04%)、滤泡性淋巴瘤(2.94%)、伯基特淋巴瘤(2.52%).两者起病部位均以颈部淋巴结常见.结论 HL和NHL发病存在性别、年龄、病理类型、起病部位等差异.
目的 分析噁性淋巴瘤患者住院的臨床特點.方法 從該院病案數據庫提取2005年1月至2009年12月住院噁性淋巴瘤患者的資料,剔除未能明確病理分型及重複入院的病例,從年齡、性彆、病理類型、腫瘤起病部位及分期等方麵進行分析、總結.結果 住院的噁性淋巴瘤患者1126例,男女比例為1.94:1.霍奇金淋巴瘤(HL)患者年齡集中在20～40歲,以混閤細胞型(64.16%)、結節硬化型(29.48%)為主.非霍奇金淋巴瘤(NHL)患者年齡以50～70歲為多,髮病率位于前10位的為瀰漫大B細胞淋巴瘤(53.31%)、結外NK/T細胞淋巴瘤(7.35%)、套細胞淋巴瘤(6.40%)、B細胞慢性淋巴細胞白血病/小淋巴細胞淋巴瘤(4.30%)、間變性大細胞淋巴瘤(4.09%)、前T細胞淋巴母細胞白血病/淋巴瘤(3.88%)、外週T細胞淋巴瘤(非特指)(3.46%)、血管免疫母細胞型淋巴瘤(3.04%)、濾泡性淋巴瘤(2.94%)、伯基特淋巴瘤(2.52%).兩者起病部位均以頸部淋巴結常見.結論 HL和NHL髮病存在性彆、年齡、病理類型、起病部位等差異.
목적 분석악성림파류환자주원적림상특점.방법 종해원병안수거고제취2005년1월지2009년12월주원악성림파류환자적자료,척제미능명학병리분형급중복입원적병례,종년령、성별、병리류형、종류기병부위급분기등방면진행분석、총결.결과 주원적악성림파류환자1126례,남녀비례위1.94:1.곽기금림파류(HL)환자년령집중재20～40세,이혼합세포형(64.16%)、결절경화형(29.48%)위주.비곽기금림파류(NHL)환자년령이50～70세위다,발병솔위우전10위적위미만대B세포림파류(53.31%)、결외NK/T세포림파류(7.35%)、투세포림파류(6.40%)、B세포만성림파세포백혈병/소림파세포림파류(4.30%)、간변성대세포림파류(4.09%)、전T세포림파모세포백혈병/림파류(3.88%)、외주T세포림파류(비특지)(3.46%)、혈관면역모세포형림파류(3.04%)、려포성림파류(2.94%)、백기특림파류(2.52%).량자기병부위균이경부림파결상견.결론 HL화NHL발병존재성별、년령、병리류형、기병부위등차이.
Objective To analyze the clinical characteristics of 1126 cases of malignant lymphoma in our hospital from 2005 to 2009. Methods Age, sex, pathological classification, onset locus and clinical staging of the malignant lymphoma were analyzed and summed up, based on the data of the malignant lymphoma patient information in hospital case database from 2005 to 2009 and excluded the cases as pathology was not sure and the repeated cases. Results A male:female ratio of malignant lymphoma in inpatient was 1.94:1. The majority of Hodgkin lymphoma (HL) manifested in 20-40 years old, mixed cellularity (64.16 %) and nodular sclerosis (29.48%) was most common. The majority of non-Hodgkin lymphoma (NHL) manifested in 50-70 years old, the most common pathological classifications were diffuse large B-cell lymphoma (53.31 %), extranode nasal-type NK/T cell lymphoma (7.35 %), mantle cell lymphoma (6.40 %), B chronic lymphocytic leukemia/small B-cell lymphoma (4.30 %), anaplastic large cell lymphoma (4.09 %), precursor T cell lymphoblastic leukemia/lymphoma (3.88 %), peripheral T cell lymphoma but not otherwise specified (3.46 %), angioimmunoblastic lymphoma(3.04 %), follicular lymphoma(2.94 %), Burkitt lymphoma (2.52 %). The onset locus of both HL and NHL most often involved lymph nodes of the cervical region. Conclusion The gender, age, pathological classification, onset locus and clinical staging of malignant lymphoma were different between HL and NHL.
